JW Pharmaceutical develops dutasteride tablet for treatment of hair loss and benign prostatic hyperplasia

Published: 2018-03-14 16:26:00
Updated: 2018-03-14 16:27:53

Developing dutasteride as tablets, JW Pharmaceutical is going to target the world’s KRW 1 trillion market.

JW Pharmaceutical announced on the 12th the company succeeded in developing ‘dutasteride,’ a hair loss and benign prostatic hyperplasia treatment which originally was a soft capsule, as a t...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.